ACORN MOBILITY SERVICES LTD.
Company number 02593771 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: Acorn Mobility Services Ltd.
Company No. 02593771 | Stairlift manufacturing & installation (Group) | FY ending 30 September 2023 (latest detailed accounts)
1. Financial Health Score: B+ (Strong, with watch items)
This is a fundamentally fit business — a strong heart (22.4% operating margin), healthy circulation (£52.4M operating cash flow), and no debt on the balance sheet. The grade is held back from an A by one clear lifestyle issue: the company is distributing more to its owner than it earns, causing its equity reserves to shrink two years' worth of retained strength in a single year.
2. Key Vital Signs
| Metric | FY2023 | FY2022 | Clinical Reading |
|---|---|---|---|
| Turnover | £255.8M | £245.4M | ✅ Healthy growth (+4.3%) |
| Gross margin | 72.7% | 70.0% | ✅ Exceptional — strong pricing power |
| Operating profit | £57.4M (22.4%) | £57.7M (23.5%) | ✅ Stable, elite-level profitability |
| Operating cash flow | £52.4M | £30.9M | ✅ Up 70% — excellent circulation |
| Bank debt | £Nil | £Nil | ✅ No borrowings |
| Net assets (company) | £34.1M | £39.4M | ⚠️ Down 13.4% — shrinking reserves |
| Cash (company) | £4.7M | £5.6M | ⚠️ Down 16% (group cash £9.8M) |
| Total liabilities | £24.5M | £18.5M | ⚠️ Up 32% — worth monitoring |
| Dividends paid | £48.4M | £29.3M | 🔴 Up 65% — exceeds earnings |
| Employees | 1,365 | 1,301 | ✅ Stable, growing workforce |
| R&D spend | £35k | £33k | 🔴 0.01% of turnover — negligible |
Derived insight: With net assets falling ~£2.4M at group level despite £48.4M of dividends, implied net profit was roughly £46M — meaning the dividend payout ratio was approximately 105% of earnings. The patient is donating more blood than it produces.
3. Diagnosis
The healthy organs: - Profitability is outstanding. A 72.7% gross margin and 22.4% operating margin place Acorn well above typical manufacturing benchmarks. This indicates genuine brand strength and pricing power in the global stairlift market. - Cash generation is vigorous. £52.4M of operating cash inflow against £57.4M operating profit shows profits are real, not paper-based. - The balance sheet carries no debt, and net assets of £34M+ provide a substantial cushion. - Risk is well-diversified: 67.6% of sales are exported, insulating against any single economy. The aging-population demographic tailwind supports long-term demand. - Governance hygiene is good: audited by Forvis Mazars, filings current, no overdue returns, 33 years of continuous trading.
The symptoms requiring attention: - Equity erosion through over-distribution. Net assets fell from £39.4M to £34.1M while dividends jumped 65%. One year of this is affordable; a sustained pattern thins the shock absorber protecting against downturns. - Rising liabilities (+32% to £24.5M) grew faster than assets (+3.7%). Not yet concerning, but the trend warrants explanation. - Chronic under-investment in R&D. Spending £35k on R&D against £256M of revenue is remarkably lean for a product manufacturer — a potential long-term competitiveness risk if competitors innovate faster. - Ownership concentration. One individual holds >75% of shares and sits on the board. This aligns the dividend policy with personal extraction preferences and creates key-person/succession considerations.
4. Prognosis
Near-term (1–2 years): Positive. Debt-free, highly profitable, cash-generative, and operating in a structurally growing market. The business can comfortably absorb cost-of-living pressures and FX volatility at current margins.
Medium-term: Guarded-positive. The trajectory depends on behaviour, not performance. If dividends continue to exceed earnings, the equity buffer (already down from £59% to ~49% of total assets) will keep thinning, reducing resilience precisely as the company pursues "ambitious sales growth" into new markets.
5. Recommendations
- Prescribe a dividend discipline. Cap distributions at 60–75% of net profit. This still returns ~£28–35M annually to shareholders while rebuilding reserves.
- Rebuild the cash buffer. Target a minimum cash position covering 3+ months of operating costs; company-level cash has fallen two consecutive periods.
- Invest in the future product pipeline. Even 0.5–1% of turnover (£1.3–2.6M) directed to R&D would materially strengthen long-term positioning at trivial cost to margins.
- Interrogate the liabilities increase. Understand what drove the £6M rise and ensure working capital cycles remain controlled as the group expands.
- Formalise succession and governance planning given the single dominant shareholder — including board independence and continuity arrangements.
- Maintain FX hedging discipline via currency matching with suppliers, given two-thirds of revenue is non-sterling.
- Stress-test the expansion plans against a downturn scenario in the largest export markets before committing growth capital.